SearchDictionaryMobileLogin

Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.

AbstractInsulin activation of the phosphatidylinositol 3-kinase (PI3K) pathway stimulates glucose uptake in peripheral tissues and synthesis of nitric oxide (NO) in the endothelium. Insulin resistance (IR) and hypertension frequently coexist, particularly among individuals with salt-sensitive hypertension. The mechanisms underlying this association are poorly understood. We investigated these mechanisms in a model of salt-sensitive hypertension in which we have previously shown that endothelial dysfunction is mediated by superoxide anion (O(2)(-)) linked to local ANG II. Dahl salt-sensitive rats were fed, for 6 wk, a normal salt diet (NS; 0.5% NaCl), high-salt diet (HS; 4% NaCl), HS plus the ANG II type 1 receptor (AT(1)R) blocker (ARB) candesartan (10 mg.kg(-1).day(-1)), or HS plus the antioxidant tempol (172 mg/l in drinking water). Hypertensive (mean arterial pressure: 145 +/- 4 vs. 102 +/- 5 mmHg in NS, P < 0.05) rats manifested increased aortic AT(1)R mRNA (210%) and protein (101%) expression and O(2)(-) production (104%) and impaired endothelium-dependent relaxation (EDR) to acetylcholine [maximal response (E(max)): 68 +/- 9 vs. 91 +/- 8% in NS, P < 0.05]. ARB or tempol normalized O(2)(-) and EDR despite that they did not normalize mean arterial pressure, which was reduced only 25%. Hypertensive rats manifested metabolic IR (36% reduction in the glucose infusion rate by insulin clamp), impaired NO-mediated insulin-induced EDR (E(max): 12 +/- 5 vs. 32 +/- 4% in NS, P < 0.05), and impaired insulin activation of PI3K/endothelial NO synthase. ARB or tempol improved insulin-mediated EDR, PI3K, Akt/ endothelial NO synthase phosphorylation, and metabolic IR (all P < 0.05). This study provides insight into the mechanisms that underlie the association between metabolic and hypertensive cardiovascular diseases and support the notion that O(2)(-) overproduction linked to tissue ANG II interferes with shared insulin signaling pathways in metabolic and cardiovascular tissues.
AuthorsMing-Sheng Zhou, Ivonne Hernandez Schulman, Leopoldo Raij (Affiliation: Nephrology-Hypertension Sect., Veterans Affairs Medical Center, and Vascular Biology Institute, Miller School of Medicine, Univ. of Miami, 1201 NW 16th St., Rm. A-1009, Miami, FL 33125, USA. mzhou2 at med.miami.edu)
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 296 Issue 3 Pg. H833-9 (Mar 2009) ISSN: 0363-6135 [Print] United States
PMID19151253 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Antioxidants
  • Benzimidazoles
  • Cyclic N-Oxides
  • RNA, Messenger
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Sodium Chloride, Dietary
  • Spin Labels
  • Tetrazoles
  • Vasodilator Agents
  • Insulin
  • Angiotensin II
  • candesartan
  • tempol
  • Acetylcholine
  • C-Reactive Protein
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Superoxide Dismutase
  • 1-Phosphatidylinositol 3-Kinase
  • JNK Mitogen-Activated Protein Kinases
  • Proto-Oncogene Proteins c-akt
Topics
  • 1-Phosphatidylinositol 3-Kinase (metabolism)
  • Acetylcholine (pharmacology)
  • Angiotensin II (metabolism)
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Animals
  • Antioxidants (pharmacology)
  • Benzimidazoles (pharmacology)
  • Blood Pressure
  • Body Weight
  • C-Reactive Protein (metabolism)
  • Cyclic N-Oxides (pharmacology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular (drug effects, metabolism, physiopathology)
  • Hypertension (drug therapy, etiology, metabolism, physiopathology)
  • Insulin (metabolism)
  • Insulin Resistance
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Male
  • Nitric Oxide Synthase Type III (metabolism)
  • Oxidative Stress (drug effects)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (metabolism)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Inbred Dahl
  • Receptor, Angiotensin, Type 1 (metabolism)
  • Receptor, Angiotensin, Type 2 (metabolism)
  • Signal Transduction (drug effects)
  • Sodium Chloride, Dietary
  • Spin Labels
  • Superoxide Dismutase (metabolism)
  • Tetrazoles (pharmacology)
  • Vasodilation
  • Vasodilator Agents (pharmacology)